OGT (@OxfordGeneTech) header
OGT (@OxfordGeneTech) profile picture

As a provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient.

Oxford, UK
Joined October 2009
Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)Photo by OGT (@OxfordGeneTech)
AML MRD analysis doesn’t have to mean complex workflows. The SureSeq™ myPanel Myeloid Fusion MRD Panel* brings fusion gene detection and analysis together in a single NGS workflow, helping laboratories like yours streamline analysis while gaining deeper molecular insights. Combining multi-gene fusion detection and integrated analysis software our solution optimises your AML MRD analysis. Discover more: ogt.com/products/product-sea… #SureSeq #AML #MRD #NGS #Genomics *For Research Use Only; Not for Use in Diagnostic Procedures
17
How sharp are your array troubleshooting skills? 🔍 Put your knowledge to the test with the latest challenge in our Arrays Quiz Series Test your ability to identify common array issues, determine their potential causes and select the most appropriate troubleshooting approach Think you can score 100%? Find out! view.genially.com/6ad09abbde… #Microarray #CytoSure #QuizSeries #Genomics #OGT
14
Today we are announcing four newly launched CytoCell® IVDR-certified probes as part of our full CytoCell IVDD portfolio transition to IVDR by the 31 December 2028 deadline. 🧬ATM Deletion Probe 🧬IGH Plus Breakapart Probe 🧬IGH/FGFR3 Plus Translocation Dual Fusion Probe 🧬IGH/MYEOV Plus Translocation Dual Fusion Probe The launch forms part of our ongoing commitment to supporting clinical cytogenetics laboratories through the transition to IVDR, ensuring a credible long-term route to portfolio continuity. Learn more about our IVDR programme: ogt.com/products/cytocell-fi… #IVDR #Cytogenetics #FISHProbes #CytoCell #Diagnostics
22
Why limit MRD analysis to a single target when disease dynamics are rarely that simple? The SureSeq myPanel™ Myeloid Fusion MRD Panel* enables highly sensitive detection of multiple fusion genes from a single assay, to support your genomic profiling of AML samples. Providing broader insights than traditional single-target approaches, SureSeq™ NGS panels help laboratories like yours evaluate residual disease with confidence while reducing analysis complexity. Broader insights. Streamlined workflows. High-sensitivity fusion detection. Discover more: ogt.com/products/product-sea… *For Research Use Only; Not for Use in Diagnostic Procedures #SureSeq #AML #MRD #NGS #Genomics
20
When library prep timing depends on who’s available, schedules slip. SureSeq™ automation on Hamilton STAR is built to help standardise execution so runs are less dependent on a small number of trained technicians. Want to talk through your workflow and staffing coverage? Contact us to schedule a walkthrough ogt.com/products/sureseq-ngs… #LabAutomation #NGSWorkflows #Genomics #LabManagement #MolecularPathology
20
As Blood Cancer Awareness Month draws to a close, put your knowledge to the test with our Blood Cancer Quiz. From leukaemia and lymphoma to multiple myeloma and the technologies supporting diagnosis, discover how much you know about blood cancers and their genomic landscape. 🧠 Take the quiz and challenge your colleagues! view.genially.com/6ab66e896d… #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology
24
Today we're recognising European Myeloma Day as part of Blood Cancer Awareness Month. Accurate detection of clinically relevant abnormalities in multiple myeloma begins with high-quality sample preparation. Optimising plasma cell enrichment can play a crucial role in supporting reliable FISH analysis and improving confidence in results. Learn more in our article exploring approaches to CD138 cell selection for multiple myeloma testing. 📖 Learn more: Optimising CD138 Cell Selection for Multiple Myeloma FISH ogt.com/resources/fish-resou… #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology #EuropeanMyelomaDay #MultipleMyeloma
31
Now Available: SureSeq™ library prep automation on Hamilton STAR is here. Minimal hands-on time. Optional pause points accommodate your workflow. Built for labs that need reproducible runs across shifts and staff. Discover more:👉ogt.com/products/sureseq-ngs… #SureSeq #LabAutomation #NGSWorkflows #Genomics #LabManagement #MolecularPathology
40
As part of Blood Cancer Awareness Month, we're recognising World ALL Day and raising awareness of acute lymphoblastic leukaemia (ALL). Cytogenetic testing remains an important component of ALL characterisation, helping laboratories identify recurrent chromosomal abnormalities associated with diagnosis and risk stratification. Explore our resource highlighting Cytocell IVD FISH probes designed to support ALL testing workflows. 📖 Learn more: CytoCell IVD FISH Probes for ALL Diagnosis ogt.com/resources/fish-resou… #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology #WorldALLDay
19
September is Blood Cancer Awareness Month, a time to raise awareness of the many diseases that fall under the blood cancer umbrella, including leukaemia, lymphoma and multiple myeloma. As genomic complexity increases, laboratories are seeking streamlined solutions that enable comprehensive analysis from a single sample. Discover how integrated testing approaches can help identify both molecular and cytogenetic drivers across blood cancers. 📖 Learn more: Integrated Blood Cancer Testing ogt.com/resources/ngs-resour… #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology #Leukaemia #Lymphoma #MultipleMyeloma
29
Need to scale your NGS runs without changing your workflow? The new SureSeq™ Unique Dual Index (UDI) expansion is designed to help laboratories scale alongside evolving sequencing needs. It increases indexing capacity from 96 up to 384 unique dual indexes, giving laboratories greater flexibility to multiplex larger numbers of samples within a single sequencing run, maximising sequencing capacity while continuing to leverage your existing SureSeq workflows. Higher throughput. Increased multiplexing flexibility. Trusted SureSeq data quality. Learn more about the SureSeq Universal NGS Workflow Solution: ogt.com/products/product-sea… #NGS #SureSeq #UniqueDualIndexing #UDIs #Genomics #Sequencing SureSeq: For research use only. Not for use in diagnostic procedures.
25
September is Blood Cancer Awareness Month, and today we're recognising World CLL Day. As our understanding of chronic lymphocytic leukaemia (CLL) continues to evolve, genomic profiling is playing an increasingly important role in supporting disease characterisation and informing decision-making. Explore this resource to learn more about the future of CLL genomics and the technologies helping laboratories uncover clinically relevant genomic alterations. 📖 Read more - The Future of CLL Genomics: ogt.com/resources/ngs-resour… #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology #WorldCLLDay #ChronicLymphocyticLeukaemia
3
37
Behind every blood cancer sample is a person waiting for answers that can help guide care decisions and improve outcomes. As Blood Cancer Awareness Month begins, we're reminded why we do what we do. At OGT, our purpose is to help advance genetic medicine by partnering with the scientists and laboratory teams whose work enables better decisions and better outcomes for patients worldwide. To the laboratory professionals whose expertise helps transform genetic insights into better patient care every day, thank you for the difference you make. #BloodCancerAwarenessMonth #BloodCancerAwareness #Haematology
19
📰 The latest DNA Dispatch newsletter is here providing you with the latest genomic updates from OGT. This edition includes scientific posters presented by leading experts and our own colleagues at the EHA Congress and AMP Europe. Check out the newsletter: ogt.com/resources/dna-dispat… #dnadispatch #ogtnews #ogtnewsletter #ogt
15
Think you’ve mastered chromosome maps? Take on our FISH Quiz Series and put your knowledge to the test 🏅 Today’s challenge: the FISH Chromosome Map Quiz. Do you have what it takes to score 100%? Find out! view.genially.com/6a69f76ea9… #FISH #CytoCell #QuizSeries #Genomics #OGT
21
The expanding CytoCell® IVDR probe portfolio now includes two newly certified prenatal aneuploidy FISH probes, designed to support compliant, validated clinical services through the IVDR transition without interruption. These new certifications form part of our commitment to transition the entire CytoCell IVDD portfolio to IVDR by the 31 December 2028 deadline, as well as a broad range of existing custom myProbes®. Learn more about our IVDR programme: ogt.com/products/cytocell-fi… #IVDR #PrenatalTesting #Cytogenetics #FISHProbes #Diagnostics
31
Today we announced our commitment to transition the full CytoCell® IVDD portfolio to IVDR by the 31 December 2028 deadline, as well as a broad range of non-IVDD probes. Having long offered a comprehensive IVDD portfolio, we are now excited to commit to supporting clinical cytogenetics labs through the transition to IVDR, with a team of clinical and technical FISH experts ready to ensure a credible long-term route to portfolio continuity. Learn more about our IVDR programme: ogt.com/products/cytocell-fi… #IVDR #Diagnostics #Cytogenetics #FISHProbes #CytoCell
1
1
58
Take on our NGS Quiz Series and put your knowledge to the test 🏆 Today’s challenge: the NGS Workflow Puzzle. Can you put the steps in the correct order to achieve a top score? Take on the challenge and find out! view.genially.com/6a3d453344… #NGS #SureSeq #QuizSeries #OGT #Genomics
1
148